# Aeson TAH System - Post-Market Clinical Follow-up Study

> **NCT05474092** · — · RECRUITING · sponsor: **Carmat SAS** · enrollment: 95 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** Aeson Total Artificial Heart

## Key facts

- **NCT ID:** NCT05474092
- **Lead sponsor:** Carmat SAS
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-11-23
- **Primary completion:** 2028-05
- **Final completion:** 2030-05
- **Target enrollment:** 95 (ESTIMATED)
- **Last updated:** 2026-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05474092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05474092, "Aeson TAH System - Post-Market Clinical Follow-up Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05474092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*